A Becciolini1, M Balzi, P Boanini
1Department of Clinical Physiopathology, University of Florence, Italy.
Thymidine Labelling Index (TLI) in breast cancer patients indicates higher proliferation in younger individuals and T2 stage tumors. TLI shows prognostic value, differentiating survival rates based on tumor proliferative activity.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: